期刊文献+

帕比司他合成工艺研究

Study on the synthetic process of panobinostat
原文传递
导出
摘要 目的改进帕比司他的合成工艺。方法以对苯二甲醛为起始原料,经还原、Knoevenagel-Doebner缩合、酯化、氯代反应合成关键中间体(E)-3-[4-(氯甲基)苯基]丙烯酸甲酯;以苯肼和5-氯-2-戊酮为原料制备中间体2-甲基色胺;两个中间体经亲核取代、氨解反应合成帕比司他。结果与结论目标物帕比司他的结构经MS和1H-NMR谱确证,纯度为99.51%(HPLC面积归一化法),总收率为32.5%。该路线操作简便,适合工业化生产。 A practical and feasible method for the preparation of panobinostat was described in this paper.The key intermediate methyl(E)-3-[(4-chloromethyl)phenyl]acrylate was synthesized from terephthalaldehyde via a four-step process with a total yield of 58.9%.Another intermediate 2-methyltryptophan was synthesized from phenylhydrazine and 5-chloro-2-pentanone through a Fischer indole synthesis with a yield of 75.4%.Panobinostat was synthesized from the two intermediates via nucleophilic substitution and ammonolysis reaction with an overall yield of 32.5%and a purity(HPLC)of 99.51%.The novel process is easy to operate and suitable for large-scale preparation.
作者 吴莉华 杨亚华 刘宏业 张美慧 董金华 WU Li-hua;YANG Ya-hua;LIU Hong-ye;ZHANG Mei-hui;DONG Jin-hua(Key Laboratory of Structure-Based Drug Design and Discovery(Shenyang Pharmaceutical University),Ministry of Education,Shenyang 110016,China;Shanghai Shengdi Medicine Co.,Ltd.,Shanghai 201210,China)
出处 《中国药物化学杂志》 CAS CSCD 北大核心 2020年第11期675-679,共5页 Chinese Journal of Medicinal Chemistry
基金 辽宁省教育厅项目(2019LJC16)
关键词 帕比司他 (E)-3-[4-(氯甲基)苯基]丙烯酸甲酯 2-甲基色胺 合成工艺 panobinostat methyl(E)-3-[(4-chloromethyl)phenyl]acrylate 2-methyltryptophan synthetic process
  • 相关文献

参考文献1

二级参考文献10

  • 1Acemoglu M,Bajwa JS,Parker DJ,et al.Process for preparation of (2E)-N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl) ethyl] amino] methyl] phenyl] -2-propenamide:WO,2007146718[P].2007-12-21.(CA2007,148:61900).
  • 2Izumo S,Shetty SS.Preparation of cinnamic acid N-hydroxy amides as histone deacetylase inhibitors for the treatment of pathologic cardiac hypertrophy and heart failure:WO,2007021682[P].2007-02-22.(CA 2007,146:274216).
  • 3Chen YNP,Lassota P,Wood AW.Cyclooxygenase-2inhibitor-histone deacetylase inhibitor combination for treatment of premalignant colon lesions,colon cancer,and other malignancies:WO,2003039599[P].2003-05-15.(CA 2003,138:362661).
  • 4Slade J,Parker D,Girgis M,et al.Optimization and scale-up of the grandberg synthesis of 2-methyltryptamine[J].Org Process Res Dev,2007,11 (4):721-725.
  • 5Bowman MD,Schrnink JR,McGowan CM,et al.Scale-up of microwave-promoted reactions to the multigram level using a sealed-vessel microwave apparatus[J].Org Process Res Dev,2008,12(6):1078-1088.
  • 6Pechlivanidis Z,Hopf H,Ernst L.Paracyclophanes:extending the bridges.synthesis[J].Eur J Org Chem,2009,(2):223-237.
  • 7Revill P,Mealy N,Serradell N,et al.Panobinostat:histone deacetylase (HDAC) inhibitor apoptosis inducer oncolytic[J].Drugs Future,2007,32 (4):315-322.
  • 8Null.抗癌药Panobinostat.药学进展,2007,:430-430.
  • 9Novartis.Novartis phase Ⅱ LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients[EB/OL].[2010-12-06].http://www.novartis.com/newsroom/media-releases/en/2010/1469475.shtml.
  • 10檀琼,刘全海.组蛋白去乙酰化酶抑制剂的研究进展[J].世界临床药物,2010,31(10):616-620. 被引量:11

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部